Alar Pharmaceuticals Inc. (TPEX:6785)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
99.10
-6.40 (-6.07%)
Jul 29, 2026, 1:30 PM CST
Market Cap6.62B -33.7%
Revenue (ttm)3.00M -48.4%
Net Income-112.77M
EPS-1.69
Shares Out 66.80M
PE Ration/a
Forward PEn/a
Dividend0.10 (0.09%)
Ex-Dividend Daten/a
Volume279,149
Open105.50
Previous Close105.50
Day's Range97.50 - 105.50
52-Week Range97.50 - 317.00
Beta0.08
Analystsn/a
Price Targetn/a
Earnings DateAug 7, 2026

About Alar Pharmaceuticals

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan. [Read more]

Sector Healthcare
Founded 2016
Employees 32
Stock Exchange Taipei Exchange
Ticker Symbol 6785
Full Company Profile

Financial Performance

Financial Statements